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as previously described (41) . Tachyzoites were allowed to infect HFFs and grown under normal 196 conditions for 1 h, before the medium was replaced with differentiation medium (alkaline media 197 with pH = 8.2, ambient CO2). The medium was replaced every day to maintain high pH. 198 Subsequently, the samples were subject to immunofluorescent analysis. All parasites were 199 stained with goat anti-Toxoplasma and bradyzoites were stained with rabbit anti-BAG1. The 
Animal infection experiments 204
For virulence assay, tachyzoites purified from freshly lysed HFF cells were used to infect mice 205 by intraperitoneal (i.p.) injection. In parallel, the accurate number of infectious parasites 206 infected with mice was determined by performing plaque assays. For immunosuppression, mice 207 were treated with dexamethasone (dexamethasone 21-phosphate disodium salt) in drinking 208 water (30 mg/liter) two days before infection (42). Drinking water was replaced second day 209 with water containing freshly prepared dexamethasone. All animals were monitored daily for 210 clinical signs and mortality for 30 days. Blood collected from mice that survived at day 30 were 211 tested by enzyme linked immunosorbent assay (ELISA) to confirm T. gondii infection. To 212 assess the cyst burden, mice were euthanized at day 30 post infection. Whole brains were 213 homogenized in PBS and the number of brains cyst was performed by examining dilutions of 214 Dolichos biflorus lectin-stained brain homogenates as previously described (43).
215
For in vivo competition assay, C57BL/6 mice were infected with a mixed aliquot of ~30% 216 Δgra12C and ~70% Δgra12. In vitro plaque assays were used to confirm the ratio of the mixed 217 inoculum. On days 4 and 7, mice were euthanized and peritoneal lavage fluids were collected monolayers were infected with the parasites for 24 h and the ratios of Δgra12C and Δgra12 221 parasite vacuoles were determined by IFA stained with mouse anti-SAG1 and rabbit anti-HA. 
RESULTS

237
Genetic removal and complementation of GRA12 in type I RH and type II Pru strains 238 To determine the function(s) of GRA12, the gra12 locus was disrupted by CRISPR-Cas9-239 mediated homologous recombination. To achieve this, a knockout construct consisting of the 240 gra12 flanking regions surrounding the dihydrofolate reductase (DHFR) selectable marker was 241 used to replace the GRA12-coding region (Fig. 1A) . After transfection of gra12 gene special 
